- ROUNDTABLE: Pharmacy’s future in sync with technology
- Reports: Mich. bill would allow marijuana sales in pharmacies
- EXPERT BLOG: Provider status for pharmacists — one way or another
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Easton Pharmaceuticals seeking investment in medical marijuana industry
ALEXANDRIA, Va. — The National Association of Specialty Pharmacy has launched a task force to investigate pharmacological management of medical marijuana, the group said.
Currently, according to NASP, there are no national standards of practice for the management of medical marijuana, though according to the National Organization for the Reform of Marijuana Laws, 21 states and the District of Columbia have legalized marijuana for medical purposes. Two of those states, Washington and Colorado, have legalized recreational use as well.
The NASP's professional practice committee will oversee a group of volunteers representing various stakeholders to develop a framework for educational content, practice parameters and other standards of care.
"Medical marijuana has come to the forefront of patient care in many of the diseases that specialty pharmacists treat, including multiple sclerosis, cancer, HIV and others," NASP CEO Gary Cohen said. "More education for physicians, pharmacists and patients is needed to ensure individuals receive the correct product with the correct efficacy and drug delivery system to fit their disease. As an organization, NASP believes that it has the responsibility, intellectual advisers and obligation to take the lead on this emerging area of medical care."